Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116848) titled 'Radiotherapy with immunotherapy in advanced renal cancer' on Sept. 1.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: Tata Memorial Centre Grant in aid insitute under DAE GoI Intramural funding
Condition:
Health Condition 1: C649- Malignant neoplasm of unspecifiedkidney, except renal pelvis
Intervention:
Intervention1: Stereotactic body radiotherapy: 42 Gy in 3 fractions or 40 Gy in 5 fractions over 1 - 2 weeks
Control Intervention...